Aurinia Pharmaceuticals (AUPH) Net Equity Issued and Repurchased (2021 - 2025)
Aurinia Pharmaceuticals (AUPH) posted Net Equity Issued and Repurchased of $355000.0 for Q4 2025, down 6.82% on a QoQ basis from $381000.0 in Q4 2024, and down 6.82% year-over-year from $381000.0 in Q4 2024.
Aurinia Pharmaceuticals (AUPH) Net Equity Issued and Repurchased (2021 - 2025) Analysis & Trends
Aurinia Pharmaceuticals' Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $355000.0 for Q4 2025.
- Quarterly Net Equity Issued and Repurchased fell 6.82% year-over-year to $355000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $736000.0 (down 99.63% YoY) and the FY2025 annual result came in at $756000.0, down 30.26% from the prior year.
- Net Equity Issued and Repurchased was $355000.0 for Q4 2025 at Aurinia Pharmaceuticals, down from $381000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $196.7 million in Q4 2021 and bottomed at $355000.0 in Q4 2025.
- A 3-year average of $65.8 million and a median of $381000.0 in 2024 frame the typical range for Net Equity Issued and Repurchased.
- Peak annual rise in Net Equity Issued and Repurchased reached 6.82% in 2025, while the deepest fall reached 6.82% in 2025.
- Aurinia Pharmaceuticals' Net Equity Issued and Repurchased stood at $196.7 million in 2021, then plunged by 99.81% to $381000.0 in 2024, then slipped by 6.82% to $355000.0 in 2025.
- Business Quant data shows AUPH's Net Equity Issued and Repurchased at $355000.0 in Q4 2025, $381000.0 in Q4 2024, and $196.7 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 355,000.00 |
| Dec 31, 2025 | 355,000.00 |
| Dec 31, 2024 | 381,000.00 |
| Dec 31, 2024 | 381,000.00 |
| Dec 31, 2021 | 196.74 Mn |
| Dec 31, 2021 | 196.74 Mn |